1984; Majima et al. 1985) . Two of them, which inhibited the augmentation of NK cells by interferon (IFN), were found to be uracil and uric acid ). Another, which impaired the resistance of mice to Listeria infection, is now known to be 1-methyladenosine (m1Ado) ).
Evaluation of immunosuppressive activities by antibacterial resistance in mice is complicated and time consuming. Consequently, we have endeavoured to establish a rapid and simple in vitro assay system, by utilizing the luminoldependent CL generated by Mq s after stimulation with opsonized zymosan. Mss were used because of the following observations : Suppressor Mss may play the most critical role in T cell function after PHA or Con A stimulation (Shibata et al. 1983 ) and also in the induction of IFN y by human peripheral mononuclear cells (Yamaguchi et al. 1984 ; Noda et al. 1986 ).
Thus the main purpose of this report is to evaluate our in vitro test by comparing it with the in vivo and the in vivo-in vitro tests. As for the immunosuppressive agents, we used mainly the modified nuclosides and bases employed in previous experiments ).
MATERIALS AND METHODS

Mice used for immunosuppression test
Male BALB/c mice were obtained from the Shizuoka Agricultural Cooperative Association for Laboratory Animals (Hamamatsu). They were maintained in an air conditioned room with free access to a basal diet and water, and used at 6 to 10 weeks old.
Nucleosides and other chemicals
All purine and pyrimidine derivatives were purchased from Sigma Chemical Co. (St. Louis, MO, USA) and Wako Pure Chemical (Osaka). 2'-Deoxy-l-methyladenosine (m'dAdo) was synthesized from 2'-deoxyadenosine (dAdo) according to the method of Jones and Robins (1963) . All these nucleoside derivatives were 99% or more pure according to HPLC analysis. Luminol was purchased from Wako Pure Chemical and Zymosan A from Sigma. Brain heart infusion (BHI) medium and heart infusion agar (HIA) were obtained from Difco Laboratories (Detroit, MI, USA).
Bacteria used for immunosuppression experiments in mice
Listeria monocytogenes (serotype 4b), isolated from the spinal fluid of a patient with Listeria meningitis was grown in Bill medium at 37°C for 15 hr and then centrifuged at 3,000 rpm for 30 min to collect organisms. The number of live organisms was counted by plating on HIA. The organisms were suspended at 1 x 109 cells/ml in the Bill medium, and aliquots were stored at -80°C until use. A median lethal dose (LD50) was 1-2X106 when given intravenously (i.v.) to BALB/c mice.
Preparation of peritoneal macrophage suspensions
Lm-Mqs used for the in vitro test were obtained from BALB/c mice 4 days after intraperitoneal (i.p.) injection of live Listeria, l x 106 cells/mouse. Peritoneal Mqs used for the in vivo-in vitro test were obtained from mice 2 days after i.p. injection of nucleosides or saline-control.
These peritoneal cells were harvested after i.p. injection of 6 ml of cold RPMI 1640 medium supplemented with 100 U/ml penicillin G and 100,ag/ml streptomycin (RPMI), followed by recovery (5 ml) within 2 min. The harvested cells were washed twice with RPMI and finally resuspended in RPMI at 1 X 106 cells ml.
In vivo test for detecting suppressive activities of nucleosides against Listeria infection (in vivo test)
Evaluation of the effect of the nucleosides on Listeria resistance was performed according to the method previously described (Takano et al. 1983 ). Briefly, 0.2 ml aliquots of nucleosides dissolved in saline (0.02 mM) were given i.v. to BALB/c mice 24 hr before Listeria infection. The control mice were given 0.2 ml of saline. After i.v. challenge of 1 LD50 dose of Listeria, the progress of the survivors was followed for 20 consecutive days.
Measurement of luminol dependent CL generation by nucleoside treated macrophages (in vitro test)
One ml aliquots of Lm-M~b suspension (1 X 106 cells) prepared as described above were put in plastic vials and placed in a 5% COZ incubator at 37°C. Two hr later, nonadherent cells were counted and removed. The remaining adherent cells were washed three times with RPMI, then cultured with 1 ml of RPMI containing 5° heat-inactivated fetal calf serum (FCS-RPMI) and tested nucleosides dissolved in saline (0.3 mM) were added to the cultures. After 18 hr incubation, the nucleoside solution was discarded and adherent cells were washed three times with RPMI, then incubated with 1 ml of FCS-RPMI. Ten ul of luminol dissolved in RPMI (0.2 mg/ml) was added to each vial and set to a liquid scintillation spectrometer (Biolumat LB 9500T, Berthold, Germany). When, after 2 min, the background count became constant, 40,u1 of Zymosan A opsonized with fresh autologous serum (25 mg ml) was added to the vial, on the understanding that opsonized particles would react with Fc receptors of macrophages (Cheung et al. 1983 ). Photocounting of each vial was continued every minute for 30 min. Mq CL generation was assessed by the peak height and represented as counts per minute (cpm) per 105 cells. The CL analysis was done in duplicate or quadruplicate and t test was used to assess the statistical significance.
RESULTS
Effect of m1Ado on mouse Listeria infection (in vivo test)
Based upon previous experimental results ), m'Ado and its related compounds, Ado, Ino, and mldAdo were tested at 0.02 mM concentrations (the most effective dose for the enhancement of Listeria infection) by i.v. injections of 0.2 ml solution, to evaluate the impairment of resistance or the enhancement of infection in mice challenged 24 hr later with 1 LD50 of Listeria (Fig. 1) . As a result, deaths in the control mice given saline as well as in those receiving Ado and Ino reached 50% by days 6-8. As had been expected, all mice receiving m1Ado died within 5 days. Unexpected results were obtained with mldAdo, with mice proving rather resistant to the infection.
Effect of intraperitoneal administration of m1Ado on CL generation by harvested macrophages (in vivo -in vitro test)
It is already known that Mss play an important role in the elimination of Listeria in mice (Mitsuyama et al. 1978) . In confirmation of this, the suppressive effect of m1Ado on the resistance of mice to Listeria infection was demonstrated ), the mechanism being partly explained by the impaired migration of Mss to the peritoneal cavity. To transfer this in vivo observation to an in vitro experiment and also to discover whether the impairment can be found with harvested Mqs obtained from treated mice, 0.7 mM m'Ado or Ado (the optimal concentration determined by a preliminary test) were given i.p. to mice and peritoneal M q s were harvested after 2 days. Their in vitro activities were examined after incubation for 2 or 18 hr in vitro. The latter incubation period was chosen to exclude the activities of neutrophils, if any ( Table 1 ). The CL generated by peritoneal Mss obtained from m'Ado-treated mice was approximately 30% of control Mqs, whereas Mqs obtained from Ado-treated mice generated as much CL as control Mqs. As far as the two analogues are concerned, the in vitro results were consistent with the in vivo results, shown before. Suppressive effect on CL generated by macrophages when m1Ado was added in vitro (in vitro test) The effect of in vitro treatment with m1Ado on the CL generated by Lm-Mgis was then examined to establish a rapid and simple assay system. In this test, an optimal concentration of m1Ado was chosen 0.3 mM, which was the most effective and non-toxic dose, as shown in Fig. 2 . Lm-Ms were incubated in the presence of 0.3 mM m1Ado and the result is illustrated in Fig. 3 , which shows the suppressive effect of m1Ado. The suppression reached almost 70% at 18 hr. After an 18-hr incubation with m1Ado, the culture medium was replaced by fresh FCS-RPMI and incubated again for another 48 hr. The suppressive effect of m1Ado diminished almost to nothing after 24 hr incubation (Fig. 3) , indicating that the suppressive effect of m1Ado was reversible and not lethal. The immunosuppressive effect of m1Ado had been revealed not only in the in vivo Listeria challenge test, but also in the in vivo-in vitro test and again in this in vitro test.
Screening results of immunosuppressive nucleosides by means of in vitro test with Lm-Mcs
When the suppressive effect of 10 compounds including immunosuppressive nucleosides and their components was examined on the CL generated by Lm-M4s (Table 2 ), m6Ado and Ado were found to possess suppressive effects comparable to that of m'Ado. As had been expected, m'dAdo and Ino did not reveal any suppressive effect. On the other hand, dAdo and 1-methylinosine (m'Ino) showed a moderate suppressive effect, which requires further examination and explanation. 1-Methyladenine (m'Ade), a base moiety of m'Ado, was shown to have a slight suppressive effect, although D-ribose, a sugar moiety of m'Ado, had no suppressive effect. 2-Chloroadenosine (2-ClAdo) had a potent suppressive effect probably due to its known cidal effect on Mss (Ohtani et al. 1982; Saito and Yamaguchi 1985) . In summary, the results obtained are almost consistent with our prior hypothesis. The details are left for the discussion. 
DISCUSSION
The present study was conducted to see whether evaluation of the immunosuppressive effect of the principles detectable in cancer ascitic fluids (e.g. m1Ado) can be made by means of a simple in vitro test. For this purpose, Listeria-elicited (both FcRI and FcRII activated) Mqs (Majima et al. 1989) were treated with these principles in vitro for 18 hr and examined for CL after the addition of opsonized zymosan, on the supposition that it would bind to the Fc receptors of M ~bs.
M'Ado, known to have a potent suppressive activity on the resistance of mice to Listeria infection (in vivo test), was found to suppress the CL generated by Mcs obtained from pretreated mice (in vivo-in vitro test), as well as Lm-Mq CL generation in in vitro treatment (in vitro test). On the other hand, midAdo, which has an enhancing effect or no suppressive effect on the resistance to Listeria infection in mice, showed no suppressive or enhancing effect on Lm-M~ CL generation in the in vitro test. With this compound, m'dAdo, we had already found another in vivo enhancing effect on the primary antibody response to a T-dependent antigen (unpublished data). The enhancing effect of m'dAdo on resistance to Listeria infection might be attributed not to the activation of Mqs but to that of T or B cells. Ino, showing no suppressive effect on resistance to Listeria infection, had no inhibitory effect in the in vitro test.
The only exceptional or discordant finding in the three tests was obtained with Ado. The compound had a suppressive effect neither on the resistance of mice to Listeria infection nor on CL generated by Mqs obtained from Ado-treated mice. However, the compound showed a potent inhibitory effect comparable to the effect of m1Ado when treated in vitro. From a theoretical point of view, the ineffectiveness of Ado in the in vivo and the in vivo-in vitro tests can be explained by the conversion of Ado to an inactive form, probably by purine metabolic enzymes in the body fluid (Agarwal et al. 1975 ). On the other hand, the fact that m1Ado revealed a potent suppressive effect both in vivo and in vitro suggests that ml Ado might be resistant to these purine metabolic enzymes. In fact, it is well known that m1Ado is an inhibitor of adenosine deaminase (ADA) (Agarwal et al. 1975) , and m1Ado has an etiological role in an immunological disorder, that mimics adenosine deaminase deficiency syndrome.
It is also known that Ado plays an important role in the modulation of cellular functions (Berne 1980; Schimmel 1980) . In this study, adenosine and its analogues such as m1Ado, m6Ado and dAdo other than m'dAdo showed potent suppressive activities on the CL generated by Mqs in vitro (Table 2 ). It is reported that Ado suppresses the production of active oxygen metabolites in human polymorphonuclear leukocytes (PMN) (Cronstein et al. 1985; Pasini et al. 1985; Roberts et al. 1985) and the lysosomal enzyme secretion of mouse peritoneal M q s (Riches et al. 1985 ) . (Table 2) . Moreover, an in vitro suppressive effect did appear when noneffective dose of m'Ado and Ado were added simultaneously (data not shown). From these observations, the suppression of CL generation by m'Ado and Ado might be mediated by their binding to specific receptors shared by the two compounds. Identification of the subtypes of Ado receptor(s) on Lm-M~b and elucidation of the mechanism of the suppression caused by m'Ado and Ado are now in progress.
